3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Cystitis, Interstitial
1
Interventions
pembrolizumab
1273
Specimen Handling
871
Carboplatin
832
Magnetic Resonance Spectroscopy
808
Cyclophosphamide
803
Cisplatin
729
Nivolumab
659
Paclitaxel
631
Radiotherapy
574
Gemcitabine
572
Biopsy
529
Bevacizumab
476
Dexamethasone
440
fludarabine
407
Docetaxel
378
venetoclax
370
Oxaliplatin
365
Capecitabine
358
Fluorouracil
355
atezolizumab
344
durvalumab
334
Rituximab
333
Doxorubicin
317
Radiosurgery
309
Pemetrexed
306
Drug Therapy
303
Ipilimumab
294
Standard of Care
293
Etoposide
285
Radiation
281
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
chondroitin sulfate, sodium hyaluronate drug combination
×
1 year
×
Clear all
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled